Since pharmaceutical companies have entered the competition to manufacture COVID-19 vaccines, there has been an unprecedented demand for sterile vials. Manufacturers in the sterile vials market are taking advantage of this opportunity and are working at break-neck speeds to maintain robust supply chains. Stevanato Group - a provider of integrated containment and delivery solutions for the biopharmaceutical industry, has amped up its production of sterile vials for COVID-19 vaccines.
Since an increasing number of patients and individuals has been stocking medical supplies, owing to uncertainty during coronavirus curfews and lockdowns, manufacturers in the sterile vials market have been able to stay afloat during the peak pandemic period. Such manufacturers are anticipated to stay in the business during Q2 and Q3 of FY2021 due to reported COVID-19 infection in individuals amidst the gap between first and second dose of a vaccine.
While pharmaceutical companies are highly focused on coronavirus vaccine development, they are also considering primary packaging alternatives to fill, store, and distribute billions of vaccine doses worldwide. However, pharma companies are facing a global shortage of borosilicate glass due to unexpected and unprecedented demand for sterile vials. On the other hand, ordinary plastics increase risk of compromising drug efficacy and stability. Hence, companies in the sterile vials market are increasing their research in hybrid packaging solutions involving SiO2 (Silica) Materials Science that combines glass and plastic without their respective drawbacks.
The sterile vials market is predicted to expand at a favorable CAGR of ~8% during the assessment period. Manufacturers are collaborating with the highest quality machine suppliers to achieve vial sterility until the filling area, avoid contamination, and match filling technology standards. SGD Pharma is gaining popularity for supplying sterile vials produced and controlled in severe conditions to guarantee patient safety and protect the physical integrity of the vials.
Companies in the sterile vials market are increasing the availability of high quality sterile and depyrogenated molded glass vials that are gaining prominence in the pharmaceutical primary packaging industry. ISO complaint standard finish neck and strong packaging in vials is being preferred to withstand extreme conditions encountered during the lyophilization process.
Innovative pharmaceutical packaging solutions for oral liquids pertaining to human health and sterile injectables for animal health are translating into revenue opportunities for companies in the sterile vials market. Honeywell International Inc. - the U.S. publicly traded multinational conglomerate, has announced its Aclar Edge pharmaceutical packaging solution made using their proprietary multi-layer extrusion blow molding technology. Manufacturers are taking cues from such innovations to adopt technologies that improve user safety during handling and administration.
Novel sterile vials and bottles help to preserve the shelf life of oral liquids and sterile injectables for a large variety of challenging applications. Manufacturers in the sterile vials market are bolstering their output capacities in containers that perform robust moisture barrier and enhanced oxygen barrier as compared to polymeric containers.
Companies in the sterile vials market are expanding their revenue streams in cryopreservation tubes. Maxxline® is being highly publicized as a high-quality Danish brand, delivering exceptional sterile cryovials to provide contamination-free sample collection systems. Companies are increasing efforts to provide sterility assurance for each cryopreservation tube in order to adhere with contaminant-free workflows.
Manufacturers in the sterile vials market are producing cryopreservation vials and packaging, which is free from detectable heavy metal contamination. In order to boost their credibility in the competitive market landscape, manufacturers are conducting quality checks against cytotoxic substances and any detectable RNases/DNases. As such, there is a growing demand for leak-proof sterile cryopreservation vials of external thread designs that reduce the risk of contamination without adding bulk to the cryopreservation tube.
Analysts’ Viewpoint
The ever-evolving nature of COVID-19 strains and reported infection in individuals amidst the gap between first and second dose of vaccine is anticipated to generate continued revenue flow, owing to the demand for sterile vials. The sterile vials market offers a value projection of US$ 12 Bn by 2031. However, breakage, cracks, and delamination are longstanding problems in lyophilization glass vials that result in an increasing number of product recalls. Hence, companies should collaborate with the highest quality machine suppliers to drive improvements in new and strong materials that protect the physical integrity of vials and prevent contamination.
Sterile Vials Market – Segmentation
| Product |
|
| Volume |
|
| Material |
|
| End User |
|
| Region |
|
Sterile vials market was valued over US$ 4.6 Bn in 2020 and is expected to reach valuation of US$ 12 Bn by 2031
Sterile vials market is anticipated to expand at a CAGR of 8% from 2021 to 2031
Sterile vials market is driven by increase in global geriatric population, rise in awareness among consumers about infections, and growth of biologics and combination drug/device products across the globe
The sterile empty vial segment held major sterile vials market and the trend is projected to continue during the forecast period
Key players in the global sterile vials market include Adelphi Healthcare Packaging, APG Europe, Bormioli Pharma S.p.a., Corning Incorporated, Dalton Pharma Services, DWK Life Sciences GmbH
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Sterile Vials Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Trends
4.4. Global Sterile Vials Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
5. Key Insights
5.1. Recent Development (industry updates, merger & acquisitions)
5.2. Key Vendor and Distributor Analysis
5.3. Sterile Vials Pricing Analysis
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Sterile Vials Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value and Volume Forecast by Product, 2017–2031
6.3.1. Sterile Empty Vial
6.3.1.1. Sterile Evacuated Vial
6.3.1.2. Sterile Nitrogen Filled Vial
6.3.1.3. Sterile Air Filled Vial
6.3.2. Sterile Liquid Filled Vial
6.3.2.1. Sterile Saline Filled Vial
6.3.2.2. Sterile Media Filled Vial
6.3.2.3. Sterile Water Filled Vial
6.3.3. Individual Sterilized Components (ISCs)
6.4. Market Attractiveness Analysis, by Product
7. Global Sterile Vials Market Analysis and Forecast, by Volume
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value and Volume Forecast, by Volume, 2017–2031
7.3.1. <2ml
7.3.2. 2 ml to 5ml
7.3.3. 5 ml to 10 ml
7.3.4. 10 ml to 20 ml
7.3.5. >20ml
7.4. Market Attractiveness Analysis, by Volume
8. Global Sterile Vials Market Analysis and Forecast, by Material
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Material, 2017–2031
8.3.1. Glass
8.3.2. Plastic
8.4. Market Attractiveness Analysis, by Material
9. Global Sterile Vials Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value and Volume Forecast, by End-user, 2017–2031
9.3.1. Clinical Labs
9.3.2. Compounding Labs
9.3.3. Biopharmaceutical Companies
9.3.4. CMOs
9.3.5. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Sterile Vials Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value and Volume Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Sterile Vials Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value and Volume Forecast, by Product, 2017–2031
11.2.1. Sterile Empty Vial
11.2.1.1. Sterile Evacuated Vial
11.2.1.2. Sterile Nitrogen Filled Vial
11.2.1.3. Sterile Air Filled Vial
11.2.2. Sterile Liquid Filled Vial
11.2.2.1. Sterile Saline Filled Vial
11.2.2.2. Sterile Media Filled Vial
11.2.2.3. Sterile Water Filled Vial
11.2.3. Individual Sterilized Components (ISCs)
11.3. Market Value and Volume Forecast, by Volume, 2017–2031
11.3.1. <2ml
11.3.2. 2 ml to 5ml
11.3.3. 5 ml to 10 ml
11.3.4. 10 ml to 20 ml
11.3.5. >20ml
11.4. Market Value & Volume Forecast, by Material, 2017–2031
11.4.1. Glass
11.4.2. Plastic
11.5. Market Value and Volume Forecast, by End-user, 2017–2031
11.5.1. Clinical Labs
11.5.2. Compounding Labs
11.5.3. Biopharmaceutical Companies
11.5.4. CMOs
11.5.5. Others
11.6. Market Value and Volume Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Volume
11.7.3. By Material
11.7.4. By End-user
11.7.5. By Country
12. Europe Sterile Vials Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value and Volume Forecast, by Product, 2017–2031
12.2.1. Sterile Empty Vial
12.2.1.1. Sterile Evacuated Vial
12.2.1.2. Sterile Nitrogen Filled Vial
12.2.1.3. Sterile Air Filled Vial
12.2.2. Sterile Liquid Filled Vial
12.2.2.1. Sterile Saline Filled Vial
12.2.2.2. Sterile Media Filled Vial
12.2.2.3. Sterile Water Filled Vial
12.2.3. Individual Sterilized Components (ISCs)
12.3. Market Value and Volume Forecast, by Volume, 2017–2031
12.3.1. <2ml
12.3.2. 2 ml to 5ml
12.3.3. 5 ml to 10 ml
12.3.4. 10 ml to 20 ml
12.3.5. >20ml
12.4. Market Value & Volume Forecast, by Material, 2017–2031
12.4.1. Glass
12.4.2. Plastic
12.5. Market Value and Volume Forecast, by End-user, 2017–2031
12.5.1. Clinical Labs
12.5.2. Compounding Labs
12.5.3. Biopharmaceutical Companies
12.5.4. CMOs
12.5.5. Others
12.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Volume
12.7.3. By Material
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Sterile Vials Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value and Volume Forecast, by Product, 2017–2031
13.2.1. Sterile Empty Vial
13.2.1.1. Sterile Evacuated Vial
13.2.1.2. Sterile Nitrogen Filled Vial
13.2.1.3. Sterile Air Filled Vial
13.2.2. Sterile Liquid Filled Vial
13.2.2.1. Sterile Saline Filled Vial
13.2.2.2. Sterile Media Filled Vial
13.2.2.3. Sterile Water Filled Vial
13.2.3. Individual Sterilized Components (ISCs)
13.3. Market Value and Volume Forecast, by Volume, 2017–2031
13.3.1. <2ml
13.3.2. 2 ml to 5ml
13.3.3. 5 ml to 10 ml
13.3.4. 10 ml to 20 ml
13.3.5. >20ml
13.4. Market Value & Volume Forecast, by Material, 2017–2031
13.4.1. Glass
13.4.2. Plastic
13.5. Market Value and Volume Forecast, by End-user, 2017–2031
13.5.1. Clinical Labs
13.5.2. Compounding Labs
13.5.3. Biopharmaceutical Companies
13.5.4. CMOs
13.5.5. Others
13.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Volume
13.7.3. By Material
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Sterile Vials Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value and Volume Forecast, by Product, 2017–2031
14.2.1. Sterile Empty Vial
14.2.1.1. Sterile Evacuated Vial
14.2.1.2. Sterile Nitrogen Filled Vial
14.2.1.3. Sterile Air Filled Vial
14.2.2. Sterile Liquid Filled Vial
14.2.2.1. Sterile Saline Filled Vial
14.2.2.2. Sterile Media Filled Vial
14.2.2.3. Sterile Water Filled Vial
14.2.3. Individual Sterilized Components (ISCs)
14.3. Market Value and Volume Forecast, by Volume, 2017–2031
14.3.1. <2ml
14.3.2. 2 ml to 5ml
14.3.3. 5 ml to 10 ml
14.3.4. 10 ml to 20 ml
14.3.5. >20ml
14.4. Market Value & Volume Forecast, by Material, 2017–2031
14.4.1. Glass
14.4.2. Plastic
14.5. Market Value and Volume Forecast, by End-user, 2017–2031
14.5.1. Clinical Labs
14.5.2. Compounding Labs
14.5.3. Biopharmaceutical Companies
14.5.4. CMOs
14.5.5. Others
14.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Volume
14.7.3. By Material
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Sterile Vials Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value and Volume Forecast, by Product, 2017–2031
15.2.1. Sterile Empty Vial
15.2.1.1. Sterile Evacuated Vial
15.2.1.2. Sterile Nitrogen Filled Vial
15.2.1.3. Sterile Air Filled Vial
15.2.2. Sterile Liquid Filled Vial
15.2.2.1. Sterile Saline Filled Vial
15.2.2.2. Sterile Media Filled Vial
15.2.2.3. Sterile Water Filled Vial
15.2.3. Individual Sterilized Components (ISCs)
15.3. Market Value and Volume Forecast, by Volume, 2017–2031
15.3.1. <2ml
15.3.2. 2 ml to 5ml
15.3.3. 5 ml to 10 ml
15.3.4. 10 ml to 20ml
15.3.5. >20ml
15.4. Market Value & Volume Forecast, by Material, 2017–2031
15.4.1. Glass
15.4.2. Plastic
15.5. Market Value and Volume Forecast, by End-user, 2017–2031
15.5.1. Clinical Labs
15.5.2. Compounding Labs
15.5.3. Biopharmaceutical Companies
15.5.4. CMOs
15.5.5. Others
15.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Volume
15.7.3. By Material
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competitive Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Company Profiles
16.2.1. Adelphi Healthcare Packaging (The Adelphi Group Of Companies)
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Strategic Overview
16.2.1.5. SWOT Analysis
16.2.2. APG Europe
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Strategic Overview
16.2.2.5. SWOT Analysis
16.2.3. Bormioli Pharma S.p.a.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Strategic Overview
16.2.3.5. SWOT Analysis
16.2.4. Corning Incorporated
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Strategic Overview
16.2.4.5. SWOT Analysis
16.2.5. Dalton Pharma Services
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Strategic Overview
16.2.5.5. SWOT Analysis
16.2.6. DWK Life Sciences GmbH
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Strategic Overview
16.2.6.5. SWOT Analysis
16.2.7. Gerresheimer AG
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Strategic Overview
16.2.7.5. SWOT Analysis
16.2.8. Nipro Corporation
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Strategic Overview
16.2.8.5. SWOT Analysis
16.2.9. O.Berk Company
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Strategic Overview
16.2.9.5. SWOT Analysis
16.2.10. Pacific Vial
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Financial Overview
16.2.10.3. Product Portfolio
16.2.10.4. Strategic Overview
16.2.10.5. SWOT Analysis
16.2.11. Piramal Glass (Piramal Enterprises Ltd.)
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Financial Overview
16.2.11.3. Product Portfolio
16.2.11.4. Strategic Overview
16.2.11.5. SWOT Analysis
16.2.12. Schott AG
16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.12.2. Financial Overview
16.2.12.3. Product Portfolio
16.2.12.4. Strategic Overview
16.2.12.5. SWOT Analysis
16.2.13. SDG Pharma
16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.13.2. Financial Overview
16.2.13.3. Product Portfolio
16.2.13.4. Strategic Overview
16.2.13.5. SWOT Analysis
16.2.14. Shandong Pharmaceutical Glass Co. Ltd.
16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.14.2. Financial Overview
16.2.14.3. Product Portfolio
16.2.14.4. Strategic Overview
16.2.14.5. SWOT Analysis
16.2.15. SiO2 Materials Science
16.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.15.2. Financial Overview
16.2.15.3. Product Portfolio
16.2.15.4. Strategic Overview
16.2.15.5. SWOT Analysis
16.2.16. Stevanato Group
16.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.16.2. Financial Overview
16.2.16.3. Product Portfolio
16.2.16.4. Strategic Overview
16.2.16.5. SWOT Analysis
16.2.17. Thermo Fisher Scientific, Inc.
16.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.17.2. Financial Overview
16.2.17.3. Product Portfolio
16.2.17.4. Strategic Overview
16.2.17.5. SWOT Analysis
16.2.18. West Pharmaceutical Services, Inc.
16.2.18.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.18.2. Financial Overview
16.2.18.3. Product Portfolio
16.2.18.4. Strategic Overview
16.2.18.5. SWOT Analysis
List of Tables
Table 01: Global Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031
Table 03: Global Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 04: Global Sterile Vials Market Volume (Million Units) Forecast, by Product, 2017-2031
Table 05: Global Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031
Table 06: Global Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 07: Global Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031
Table 08: Global Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031
Table 09: Global Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 10: Global Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031
Table 11: Global Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 12: Global Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031
Table 13: Global Sterile Vials Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 14: Global Sterile Vials Market Volume (Million Units) Forecast, by Region, 2017-2031
Table 15: North America Sterile Vials Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 16: North America Sterile Vials Market Volume (Million Units) Forecast, by Country, 2017-2031
Table 17: North America Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 18: North America Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031
Table 19: North America Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 20: North America Sterile Vials Market Volume(Million Units) Forecast, by Product, 2017-2031
Table 21: North America Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031
Table 22: North America Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 23: North America Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031
Table 24: North America Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031
Table 25: North America Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 26: North America Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031
Table 27: North America Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 28: North America Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031
Table 29: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 30: Europe Sterile Vials Market Volume (Million Units) Forecast, by Country/Sub-region, 2017-2031
Table 31: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 32: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031
Table 33: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 34: Europe Sterile Vials Market Volume(Million Units) Forecast, by Product, 2017-2031
Table 35: Europe Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031
Table 36: Europe Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 37: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031
Table 38: Europe Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031
Table 39: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 40: Europe Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031
Table 41: Europe Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 42: Europe Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031
Table 43: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 44: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by Country/Sub-region, 2017-2031
Table 45: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 46: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031
Table 47: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 48: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031
Table 49: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 50: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031
Table 51: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031
Table 52: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 53: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031
Table 54: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 55: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031
Table 56: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 57: Latin America Sterile Vials Market Volume (Million Units) Forecast, by Country, 2017-2031
Table 58: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 59: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031
Table 60: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 61: Latin America Sterile Vials Market Volume(Million Units) Forecast, by Product, 2017-2031
Table 62: Latin America Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031
Table 63: Latin America Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 64: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031
Table 65: Latin America Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031
Table 66: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 67: Latin America Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031
Table 68: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 69: Latin America Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031
Table 70: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 71: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by Country/Sub-region, 2017-2031
Table 72: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 73: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031
Table 74: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 75: Middle East & Africa Sterile Vials Market Volume(Million Units) Forecast, by Product, 2017-2031
Table 76: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031
Table 77: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031
Table 78: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031
Table 79: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031
Table 80: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 81: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031
Table 82: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 83: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Sterile Vials Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Sterile Vials Market Value Share, by Product, 2020
Figure 03: Global Sterile Vials Market Value Share, by Volume, 2020
Figure 04: Global Sterile Vials Market Value Share, by Region, 2020
Figure 05: Global Sterile Vials Market Value Share, by Material, 2020
Figure 06: Global Sterile Vials Market Value Share, by End-user, 2020
Figure 07: Global Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031
Figure 08: Global Sterile Vials Market Attractiveness Analysis, by Product, 2021–2031
Figure 09: Global Sterile Vials Market Value (US$ Mn), by Sterile Empty Vial, 2017-2031
Figure 10: Global Sterile Vials Market Value (US$ Mn), by Sterile Liquid Filled Vial, 2017-2031
Figure 11: Global Sterile Vials Market Value (US$ Mn), by Individual Sterilized Components (ISCs), 2017-2031
Figure 12: Global Sterile Vials Market Value Share Analysis, by Volume, 2020 and 2031
Figure 13: Global Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031
Figure 14: Global Sterile Vials Market Value (US$ Mn), by <2ml, 2017-2031
Figure 15: Global Sterile Vials Market Value (US$ Mn), by 2 ml to 5 ml, 2017-2031
Figure 16: Global Sterile Vials Market Value (US$ Mn), by 5 to 10 ml, 2017-2031
Figure 17: Global Sterile Vials Market Value (US$ Mn), by 10 to 20 ml, 2017-2031
Figure 18: Global Sterile Vials Market Value (US$ Mn), by >20ml, 2017-2031
Figure 19: Global Sterile Vials Market Value Share Analysis, by Material, 2020 and 2031
Figure 20: Global Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031
Figure 21: Global Sterile Vials Market Value (US$ Mn), by Glass, 2017-2031
Figure 22: Global Sterile Vials Market Value (US$ Mn), by Plastic, 2017-2031
Figure 23: Global Sterile Vials Market Value Share Analysis, by End-user, 2020 and 2031
Figure 24: Global Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031
Figure 25: Global Sterile Vials Market Value (US$ Mn), by Clinical Labs, 2017-2031
Figure 26: Global Sterile Vials Market Value (US$ Mn), by Compounding Labs, 2017-2031
Figure 27: Global Sterile Vials Market Value (US$ Mn), by Biopharmaceutical Companies, 2017-2031
Figure 28: Global Sterile Vials Market Value (US$ Mn), by CMOs, 2017-2031
Figure 29: Global Sterile Vials Market Value (US$ Mn), by Others, 2017-2031
Figure 30: Global Sterile Vials Market Value Share Analysis, by Region, 2020 and 2031
Figure 31: Global Sterile Vials Market Attractiveness Analysis, by Region, 2021–2031
Figure 32: North America Sterile Vials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 33: North America Sterile Vials Market Value Share, by Country, 2020–2031
Figure 34: North America Sterile Vials Market Attractiveness Analysis, by Country, 2020–2031
Figure 35: North America Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031
Figure 36: North America Sterile Vials Market Attractiveness Analysis, by Product, 2020–2031
Figure 37: North America Sterile Vials Market Value Share (%), by Volume, 2020 and 2031
Figure 38: North America Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031
Figure 39: North America Sterile Vials Market Value Share (%), by Material, 2020 and 2031
Figure 40: North America Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031
Figure 41: North America Sterile Vials Market Value Share (%), by End-user, 2020 and 2031
Figure 42: North America Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031
Figure 43: Europe Sterile Vials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 44: Europe Sterile Vials Market Value Share, by Country/Sub-region, 2020–2031
Figure 45: Europe Sterile Vials Market Attractiveness Analysis, by Country/Sub-region, 2020–2031
Figure 46: Europe Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031
Figure 47: Europe Sterile Vials Market Attractiveness Analysis, by Product, 2020–2031
Figure 48: Europe Sterile Vials Market Value Share (%), by Volume, 2020 and 2031
Figure 49: Europe Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031
Figure 50: Europe Sterile Vials Market Value Share (%), by Material, 2020 and 2031
Figure 51: Europe Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031
Figure 52: Europe Sterile Vials Market Value Share (%), by End-user, 2020 and 2031
Figure 53: Europe Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031
Figure 54: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 55: Asia Pacific Sterile Vials Market Value Share, by Country/Sub-region, 2020–2031
Figure 56: Asia Pacific Sterile Vials Market Attractiveness Analysis, by Country/Sub-region, 2020–2031
Figure 57: Asia Pacific Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031
Figure 58: Asia Pacific Sterile Vials Market Attractiveness Analysis, by Product, 2020–2031
Figure 59: Asia Pacific Sterile Vials Market Value Share (%), by Volume, 2020 and 2031
Figure 60: Asia Pacific Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031
Figure 61: Asia Pacific Sterile Vials Market Value Share (%), by Material, 2020 and 2031
Figure 62: Asia Pacific Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031
Figure 63: Asia Pacific Sterile Vials Market Value Share (%), by End-user, 2020 and 2031
Figure 64: Asia Pacific Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031
Figure 65: Latin America Sterile Vials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 66: Latin America Sterile Vials Market Value Share, by Country/Sub-region, 2020–2031
Figure 67: Latin America Sterile Vials Market Attractiveness Analysis, by Country/Sub-region, 2020–2031
Figure 68: Latin America Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031
Figure 69: Latin America Sterile Vials Market Attractiveness Analysis, by Product, 2020–2031
Figure 70: Latin America Sterile Vials Market Value Share (%), by Volume, 2020 and 2031
Figure 71: Latin America Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031
Figure 72: Latin America Sterile Vials Market Value Share (%), by Material, 2020 and 2031
Figure 73: Latin America Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031
Figure 74: Latin America Sterile Vials Market Value Share (%), by End-user, 2020 and 2031
Figure 75: Latin America Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031
Figure 76: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 77: Middle East & Africa Sterile Vials Market Value Share, by Country/Sub-region, 2020–2031
Figure 78: Middle East & Africa Sterile Vials Market Attractiveness Analysis, by Country/Sub-region, 2020–2031
Figure 79: Middle East & Africa Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031
Figure 80: Middle East & Africa Sterile Vials Market Attractiveness Analysis, by Product, 2020–2031
Figure 81: Middle East & Africa Sterile Vials Market Value Share (%), by Volume, 2020 and 2031
Figure 82: Middle East & Africa Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031
Figure 83: Middle East & Africa Sterile Vials Market Value Share (%), by Material, 2020 and 2031
Figure 84: Middle East & Africa Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031
Figure 85: Middle East & Africa Sterile Vials Market Value Share (%), by End-user, 2020 and 2031
Figure 86: Middle East & Africa Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Sterile Vials Market
